Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin neuroprotection trial in preterm infants
ISRCTN15119574Phase 3Completed
- Sponsor
- Imperial College London
- Start
- Nov 2011
- Modality
- Small Molecules
01
Overview
Phase 3, randomised trial in traumatic brain injury (TBI) comparing Melatonin with Placebo (2 arms). Primary endpoint: Preserved fractional anisotropy. Started Nov 2011; status: completed.
02
Drugs
melatonin
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on ISRCTN15119574.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN15119574.